Geode Capital Management’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.26M Buy
2,332,279
+48,829
+2% +$26.4K ﹤0.01% 3261
2025
Q1
$1.5M Buy
2,283,450
+71,601
+3% +$47K ﹤0.01% 3155
2024
Q4
$2.26M Buy
2,211,849
+73,540
+3% +$75K ﹤0.01% 3086
2024
Q3
$1.85M Buy
2,138,309
+272,123
+15% +$236K ﹤0.01% 3153
2024
Q2
$669K Sell
1,866,186
-1,497,605
-45% -$537K ﹤0.01% 3459
2024
Q1
$2.25M Buy
3,363,791
+157,481
+5% +$106K ﹤0.01% 3070
2023
Q4
$1.74M Buy
3,206,310
+208,384
+7% +$113K ﹤0.01% 3161
2023
Q3
$1.8M Buy
2,997,926
+142,174
+5% +$85.3K ﹤0.01% 3104
2023
Q2
$3.71M Buy
2,855,752
+266,421
+10% +$346K ﹤0.01% 2854
2023
Q1
$4.56M Buy
2,589,331
+94,460
+4% +$166K ﹤0.01% 2674
2022
Q4
$7.83M Buy
2,494,871
+112,436
+5% +$353K ﹤0.01% 2418
2022
Q3
$11.7M Buy
2,382,435
+213,422
+10% +$1.05M ﹤0.01% 2119
2022
Q2
$8.98M Buy
2,169,013
+76,642
+4% +$317K ﹤0.01% 2331
2022
Q1
$12.2M Sell
2,092,371
-136,812
-6% -$795K ﹤0.01% 2220
2021
Q4
$16.7M Buy
2,229,183
+33,840
+2% +$254K ﹤0.01% 2081
2021
Q3
$19.8M Buy
2,195,343
+134,807
+7% +$1.21M ﹤0.01% 1965
2021
Q2
$24.7M Buy
2,060,536
+80,576
+4% +$964K ﹤0.01% 1830
2021
Q1
$24.8M Buy
1,979,960
+165,123
+9% +$2.07M ﹤0.01% 1739
2020
Q4
$28.3M Buy
1,814,837
+56,003
+3% +$874K ﹤0.01% 1498
2020
Q3
$16.6M Sell
1,758,834
-13,668
-0.8% -$129K ﹤0.01% 1651
2020
Q2
$15.9M Buy
1,772,502
+83,477
+5% +$748K ﹤0.01% 1660
2020
Q1
$10.8M Buy
1,689,025
+104,456
+7% +$665K ﹤0.01% 1696
2019
Q4
$13.3M Buy
1,584,569
+51,601
+3% +$432K ﹤0.01% 1814
2019
Q3
$13.9M Buy
1,532,968
+46,818
+3% +$424K ﹤0.01% 1709
2019
Q2
$16M Buy
1,486,150
+233,677
+19% +$2.52M ﹤0.01% 1640
2019
Q1
$11.9M Buy
1,252,473
+123,108
+11% +$1.17M ﹤0.01% 1774
2018
Q4
$13M Buy
1,129,365
+15,750
+1% +$181K ﹤0.01% 1604
2018
Q3
$18.9M Buy
1,113,615
+32,047
+3% +$543K 0.01% 1450
2018
Q2
$15.4M Buy
1,081,568
+243,573
+29% +$3.46M ﹤0.01% 1550
2018
Q1
$15.9M Sell
837,995
-2,109
-0.3% -$40.1K 0.01% 1425
2017
Q4
$13.8M Buy
840,104
+19,087
+2% +$313K ﹤0.01% 1515
2017
Q3
$12.3M Buy
821,017
+93,402
+13% +$1.4M ﹤0.01% 1574
2017
Q2
$6.4M Buy
727,615
+93,651
+15% +$824K ﹤0.01% 1982
2017
Q1
$3.3M Buy
633,964
+19,331
+3% +$101K ﹤0.01% 2368
2016
Q4
$1.87M Buy
614,633
+101,995
+20% +$311K ﹤0.01% 2664
2016
Q3
$2.37M Buy
512,638
+12,287
+2% +$56.9K ﹤0.01% 2450
2016
Q2
$2.9M Buy
500,351
+15,493
+3% +$89.7K ﹤0.01% 2236
2016
Q1
$2.93K Buy
484,858
+26,301
+6% +$159 ﹤0.01% 2201
2015
Q4
$4.19M Buy
458,557
+25,887
+6% +$236K ﹤0.01% 1989
2015
Q3
$2.44M Buy
432,670
+1,994
+0.5% +$11.2K ﹤0.01% 2310
2015
Q2
$4.78M Buy
430,676
+19,549
+5% +$217K ﹤0.01% 1923
2015
Q1
$6.45M Buy
411,127
+3,727
+0.9% +$58.4K ﹤0.01% 1708
2014
Q4
$6.2M Sell
407,400
-37,945
-9% -$577K ﹤0.01% 1688
2014
Q3
$4.8M Buy
445,345
+60,844
+16% +$656K ﹤0.01% 1793
2014
Q2
$5.87M Buy
384,501
+18,140
+5% +$277K ﹤0.01% 1684
2014
Q1
$6.62M Buy
366,361
+22,373
+7% +$404K ﹤0.01% 1553
2013
Q4
$4.78M Buy
343,988
+81,641
+31% +$1.13M ﹤0.01% 1744
2013
Q3
$2.75M Buy
262,347
+42,271
+19% +$443K ﹤0.01% 1980
2013
Q2
$1.72M Buy
+220,076
New +$1.72M ﹤0.01% 2136